KLRK1 and metabolic dysfunction-associated steatohepatitis: Thus, the increase in NK cells frequency, activation and expression of NKG2D and MIC A/B in livers from NASH patients (42) may be effective initially but futile at more advanced stages of disease, overall contributing to the proliferation and activation of HSC.